JinTai Technology Holdings has announced the acquisition of 90% of Shanghai Siwei Medical for RMB 250 million, aiming to enhance its data-driven healthcare solutions.

Information on the Target

In May, JinTai Technology Holdings (02228) announced an agreement through its wholly-owned subsidiary to acquire 90% of Shanghai Siwei Medical Technology Co., Ltd (known as "Siwei Medical") for RMB 250 million in cash. Following this transaction, Siwei Medical will become an indirectly-held non-wholly-owned subsidiary of JinTai Technology. The remaining 10% stake will be held by Shanghai Jiaotong University School of Medicine's investment platform, Shanghai Er Yi Investment Management Co., Ltd. Established in 2015, JinTai Technology is an innovative R&D platform that leverages quantum physics, artificial intelligence, and robotics to provide research and development solutions for industries such as pharmaceuticals and materials science. On the other hand, Siwei Medical, which was founded in 2008, is known for being the largest provider of remote electrocardiogram (ECG) diagnostic services in China, having amassed a vast database of ECG and ultrasound imaging diagnostic data.

Industry Overview in China

The digital economy in China represents a significant shift towards utilizing data to enhance productivity and operational efficiency. This economic form encompasses emerging technologies such as big data, cloud computing, the Internet of Things (IoT), blockchain, artificial intelligence, and 5G communications. As a driving force behind resource allocation and development, the digital economy facilitates trends like “new retail” and “new manufacturing,” redefining traditional business models and consumer interactions.

The manufacturing sector, in particular, has shown remarkable resilience, with a notable increase in mergers and acquisitions (M&A) activities. In May 2025, the amount of disclosed M&A transactions in the digital economy dropped significantly compared to April, with a reduction of 40.94% in the number of deals and a 37.64% drop in total

View Source

Similar Deals

Adicon Holdings Limited Crown Bioscience Inc.

2026

Other Biotechnology & Medical Research (NEC) China
佳辰资本 辐联科技

2025

Other Proprietary & Advanced Pharmaceuticals China
磐霖资本 劲方医药

2025

Other Proprietary & Advanced Pharmaceuticals China
LaNova Medicines ProBio

2025

Other Bio Therapeutic Drugs China
Johnson & Johnson Ronovo Surgical

2025

Other Advanced Medical Equipment & Technology (NEC) China
Applus+ De.Testing

2025

Other Advanced Medical Equipment & Technology (NEC) China

晶泰控股

invested in

四维医学

in 2025

in a Other deal

Disclosed details

Transaction Size: $19M

Equity Value: $3M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert